My Member
Message Center
trending topics
market reports
-
MEDICAL JAPAN 2025 OSAKA Returns to Showcase Global Innovations
2025-02-17
-
Visit MEDICAL JAPAN 2023 TOKYO and take full advantage of the business opportunities!
2023-09-01
-
US to distribute 400 million free N95 masks at CVS, Walgreens in COVID fight
2022-01-21
-
Ethiopia receives additional 2.2 mln doses of Chinese-donated COVID-19 vaccines
2022-01-21
-
Hong Kong researchers say they develop novel material able to kill COVID-19 virus
2022-01-14
-
10 million more Chinese doses on way for Kenya
2022-01-14
-
Sino-African ties on track for a brighter future
2022-01-07
-
Efforts urged to boost COVID-19 vaccine production capacity in poor countries
2022-01-07
-
UAE approves Sinopharm's new protein-based COVID-19 vaccine
2022-01-07
-
UAE approves Sinopharm's new protein-based COVID-19 vaccine
2022-01-07
-
Sinovac vaccine 'well tolerated, safe and induced humoral responses' in minors aged 3-17
The world's first trial results on minors aged 3-17 showed China's inactivated COVID-19 vaccine produced by Sinovac had good safety, tolerability, and immunogenicity in youths aged 3-17 years, the Global Times learnt from Sinovac on Tuesday.
2021-06-30 -
Efficacy of Sinopharm vaccines tops 70%, study finds
Domestic drugmaker Sinopharm's two vaccines are both more than 70 percent effective against symptomatic cases of COVID-19, according to a study published on Wednesday on the world's first third-stage clinical trial of inactivated vaccines.
2021-05-28 -
China's innovative lung cancer drug application accepted for review by US FDA
Chinese drugmaker Innovent Biologics, Inc. and the US-based pharmaceutical firm Eli Lilly and Company announced that FDA accepted for review an application for Sintilimab, an innovative lung cancer drug jointly developed by the two companies.
2021-05-25FDA -
Fosun helps world fight malaria
Fosun Pharma has supplied more than 200 million doses of anti-malaria drugs to the international society since 2005 to help with the world's malaria elimination efforts, the company said on Sunday, which marked World Malaria Day.
2021-04-27 -
China's daily output of COVID-19 vaccines reaches 5 million doses
BEIJING -- The daily output of Chinese COVID-19 vaccines has reached 5 million doses, a senior official said.
2021-03-26 -
Filling gaps in drug development
I-Mab Biopharma accelerates worldwide expansion through R&D, licensing deals
2020-10-12 -
Homemade vaccines set to rise in domestic market
In a first for Chinese drug-makers, Walvax Biotechnology Co Ltd has produced a vaccine branded Weuphoria that protects little children and infants from a variety of diseases like pneumonia, bacteremia, meningitis, otitis media and sinusitis.
2020-09-25 -
Four Chinese COVID-19 vaccines undergoing phase-3 clinical trials
BEIJING, Aug. 28 (Xinhua) -- Four Chinese COVID-19 vaccine candidates have started international phase-3 clinical trials, according to the State Council joint prevention and control mechanism against COVID-19.
2020-09-01Innovation -
Chinese researchers develop new diagnostic method for ovarian cancer
Chinese researchers have developed a non-invasive method to differentiate ovarian cancer subtypes, which could help improve therapeutic plans, according to the Chinese Academy of Sciences (CAS).
2020-08-20Innovation -
Corn oil may increase risk of diabetes among Chinese: study
Chinese researchers have found that n-6 polyunsaturated fatty acids, also known as omega-6, may increase the risk of type 2 diabetes among Chinese.
2020-08-19